Government to raise generic price of innovative drug firms

Published: 2013-01-22 07:00:00
Updated: 2013-01-22 07:00:00
The Ministry of Health and Welfare said Monday that the insurance price of 15 telmisartan generics produced by five innovative drug firms will be raised from today.

Telmisartan is an angiotensin II receptor antagonist used in the management of hypertension. It is marketed under the trade name ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.